Mylotarg 4.5Mg Injection
Call for Price
Brand: Mylotarg
Generic: Gemtuzumab Ozogamicin
Manufacturer: Pfizer
Drug class: CD33-directed antibody-drug conjugate (ADC).
Description
Introduction to Mylotarg 4.5mg Injection
Mylotarg 4.5mg Injection is a prescription medicine use to treat certain types of acute myeloid leukemia (AML). It contains gemtuzumab ozogamicin, a target cancer medicine that works by helping destroy certain leukemia cells.
Mylotarg 4.5mg Injection is given through an intravenous (IV) infusion by a qualify healthcare professional. The dose and treatment schedule depend on the patient’s condition and the doctor’s treatment plan.
Like other cancer medicines, Mylotarg may cause side effects. Patients should use this medicine only under the supervision of their doctor and report any unusual or serious symptoms during treatment.
Uses of Mylotarg 4.5mg Injection
Mylotarg 4.5mg Injection is a prescription medicine used to treat certain types of acute myeloid leukemia (AML). It contains gemtuzumab ozogamicin, a targeted cancer medicine.
Mylotarg is mainly used for patients with CD33-positive AML. It may be given alone or together with other chemotherapy medicines, depending on the patient’s condition and treatment plan.
The medicine works by targeting CD33 proteins find on certain leukemia cells. This helps deliver the medicine directly to these abnormal cells and can help destroy them.
Mylotarg 4.5mg Injection should only be give by a qualify healthcare professional under the supervision of an experienced doctor. The dose and treatment schedule depend on the patient’s age, medical condition, type of AML, and other medicines being used.
Important: Mylotarg is a strong anticancer medicine and should be used only when prescribed by a doctor. Do not use it without proper medical advice.
Storage
- Store Mylotarg 4.5mg Injection in a refrigerator at 2°C to 8°C.
- Keep the medicine in its original package to protect it from light.
- Do not freeze Mylotarg 4.5mg Injection.
- Keep it out of the reach of children and pets.
- Do not use the injection after the expiry date printed on the package.
- The prepared or diluted solution should be stored and used according to the instructions provided by your doctor or pharmacist.
Mylotarg 4.5mg Injection should be stored and handled properly to maintain its quality and effectiveness. Do not use the medicine if the vial appears damaged or if there are any concerns about its storage.
Safety Advice for Mylotarg 4.5mg Injection
Mylotarg 4.5mg Injection contains gemtuzumab ozogamicin and is used to treat certain types of acute myeloid leukemia (AML). It should only be given by a qualified healthcare professional under medical supervision.
- Liver problems: Mylotarg can cause serious liver damage, including veno-occlusive disease (VOD). Tell your doctor if you develop abdominal swelling or pain, sudden weight gain, or yellowing of the skin or eyes.
- Infusion reactions: Allergic or infusion-related reactions can occur. Patients are usually given preventive medicines before the infusion and monitored during and for at least 1 hour afterward.
- Bleeding: Mylotarg may increase the risk of serious bleeding. Report unusual bruising, bleeding, blood in urine or stool, or persistent bleeding to your doctor.
- Infections: Treatment may lower blood cell counts and increase the risk of infection. Contact your doctor if you develop fever, chills, or other signs of infection.
- Pregnancy: Mylotarg may harm an unborn baby. Women who can become pregnant should use effective contraception during treatment and discuss pregnancy plans with their doctor.
- Breastfeeding: Breastfeeding is not recommended during treatment with Mylotarg.
- Medical monitoring: Your doctor may regularly monitor your liver function, blood counts, and other health parameters during treatment.
- Allergy: Do not use Mylotarg if you have previously had a serious allergic reaction to gemtuzumab ozogamicin or any of its ingredients.
How to Use Mylotarg 4.5mg Injection
Mylotarg 4.5mg Injection contains gemtuzumab ozogamicin and is use to treat certain types of acute myeloid leukemia (AML). It is a hospital-administered cancer medicine and should not self-administer.
- Mylotarg is give by intravenous (IV) infusion by a qualified healthcare professional.
- Before the infusion, your doctor may give medicines such as acetaminophen, an antihistamine, and a corticosteroid to help reduce infusion-related reactions.
- The medicine is prepare by reconstituting the vial and then diluting it before administration.
- The diluted Mylotarg solution is generally infuse over about 2 hours using an appropriate in-line filter.
- The exact dose and treatment schedule depend on the patient’s age, body surface area, type of AML, and treatment regimen.
- Patients are monitor during and after the infusion for possible infusion-related reactions and other treatment-related complications.
Side Effects of Mylotarg 4.5mg Injection
Mylotarg 4.5mg Injection contains gemtuzumab ozogamicin and is use to treat certain types of acute myeloid leukemia (AML). Like other cancer medicines, Mylotarg may cause side effects, although not everyone experiences them.
Common Side Effects
Some common side effects may include:
- Bleeding
- Infection
- Fever
- Nausea
- Vomiting
- Constipation
- Headache
- Skin rash
- Loss of appetite
- Mouth sores or inflammation (mucositis)
- Low white blood cell count with fever (febrile neutropenia)
- Increased liver enzymes
These side effects may vary depending on the patient’s condition and other cancer treatments being give with Mylotarg.
Serious Side Effects
Mylotarg can cause serious side effects that require medical attention. These include:
- Liver problems: Mylotarg can cause serious liver injury, including hepatic veno-occlusive disease (VOD), which can sometimes be life-threatening.
- Severe bleeding: Mylotarg may increase the risk of serious or potentially fatal bleeding.
- Serious infections: Treatment can increase the risk of infections.
- Infusion-related reactions: Fever, chills, breathing problems, low blood pressure, or allergic reactions may occur during or shortly after the infusion.
When to Contact Your Doctor
Contact your doctor immediately if you experience unusual bleeding, severe abdominal swelling or pain, yellowing of the skin or eyes, difficulty breathing, severe fever, chills, or other unusual symptoms during treatment.
Mylotarg 4.5mg Injection should administer by a qualified healthcare professional. Do not stop or change your treatment without consulting your doctor.
- Explore product information and availability for mylotarg precio through YourMediKart. Customers searching for gemtuzumab ozogamicina precio can verify current pricing and product specifications with the supplier.
- Learn more about mylotarg 5mg and confirm the exact formulation and prescribed strength with your healthcare provider. If you are comparing gemtuzumab price, contact YourMediKart for current availability and applicable costs.
- Explore mylotarg price information and review the relevant product details. Customers searching for mylopic active should verify the exact product name and active ingredient before relying on any medicine information.
- Learn more about gemtuzumab cost and discuss treatment-related expenses with your healthcare provider. If you are looking for a gemtuzumab coupon or mylotarg coupon, contact the supplier to ask whether any legitimate assistance or pricing programs are available.
- For further details about gemtuzumab precio, confirm current pricing and product availability. Mylotarg contains gemtuzumab ozogamicin, a prescription anticancer medicine used for certain patients with acute myeloid leukemia. Treatment must manage by a qualify specialist because it can cause serious adverse effects, including liver toxicity and infusion-related reactions.




Reviews
There are no reviews yet.